Higt dose chemotheray compared with standard chemotherapy and lung radiation in Ewing sarcoma with pulmonary metastases. Results of the European Ewing Tumour Working initiative of National Groups, 99 trial and eWING 2008
Year: 2019
Type: article
Abstract: The R2Pulm trial was conducted to evaluate the effect of busulfan-melphalan high-dose chemotherapy with autologous stem-cell rescue (BuMel) without whole-lung irradiation (WLI) on event-free survival (main end point) and overall survival, compared with standard chemotherapy with WLI in Ewing sarcoma (ES) presenting with pulmonary and/or pleural metastases.
DOI: 10.1200/jco
Authors: DIRKSEN U, BRENNAN B, LE DELEY MC, COZIK N, VAN DEN BERG H, BHADRI V, BRICHARD B
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W6922416790
